FDA Investigator

Nicholas P Diorio

Latest inspection on record: Alsip, United States, September 2025 · records back to 2009

Human DrugsMedical Devices & Rad HealthFoods & Cosmetics

FDA inspection record · Last updated July 12, 2026

Overview

  • 90 inspections across 69 sites are on record.
  • 248 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2025-09-16.

At a glance

Inspections

90

Sites

69

Observations

248

Career since

Mar 2009

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Microbiological Testing & Consulting, LLC16 Sep 2025Human DrugsOn file
NACS, Inc.26 Jun 2025Human Drugs
Dhaliwal Labs North, LLC9 May 2025Human DrugsOn file
Korex Chicago LLC7 Feb 2025Human DrugsOn file
Fujian Nanping Green Pine Chemical Co., Ltd.12 Sep 2024Human Drugs

Sites inspected

Microbiological Testing & Consulting, LLCAlsip, United States1 insp.
NACS, Inc.Ham Lake, United States1 insp.
Dhaliwal Labs North, LLCBedford Park, United States1 insp.
Korex Chicago LLCChicago, United States1 insp.
Fujian Nanping Green Pine Chemical Co., Ltd.Nanping, China1 insp.

Co-investigators

Investigators who share inspections with this person.

Alan M Roberts4 shared
Peng Zhou3 shared
Joshua M Adams3 shared
Stefen D Mcmillan3 shared
Leslie D Hintz3 shared
Christopher D Leach2 shared
Mark I Kaspar2 shared
Bruce H Mccullough2 shared

Full investigator report

Get the verbatim findings behind Nicholas P Diorio's 248 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

Related investigators